Daily overview

Selection from Decision-Making Practice – 24/2026

Pharmeca a.s. 21. 10. 2026

In proceedings concerning the determination of the price and reimbursement of a medicinal product intended for immunisation, the State Institute for Drug Control (the Institute) clarified its approach to handling information submitted as trade secrets to substantiate foreign price references.

The Institute stated that:

  • to demonstrate the actual manufacturer's price in a...
    Are you interested in reading regular commentaries on decisions by Pharmeca a.s.? Feel free to contact us.

    At Pharmeca, we help you navigate the complex landscape of pharmaceutical and medical device information. We also offer flexible services that can be tailored to your needs at any time.

    Our market position and experience allow us to support you whenever you need expert guidance.

    Our knowledge, your opportunity.
Back to news listing